Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The chloride-bicarbonate anion exchanger AE2 is a membrane protein that mediates the electroneutral exchange of chloride (Cl^−) and bicarbonate (HCO₃^−) ions across the plasma membrane. This process is essential for maintaining ionic homeostasis, pH regulation, and fluid secretion in various epithelial tissues. It is highly expressed in the small intestine, colon, stomach, pancreas, and salivary glands, localized mainly to the basolateral membranes of epithelial cells. AE2 facilitates the exchange of Cl^− and HCO₃^− ions, which helps regulate intracellular pH. Its deficiency or dysfunction can lead to impaired bicarbonate secretion, increasing the risk for mucosal injury/inflammation, and has been implicated in digestive cancers, secretory diarrheas, and disorders involving abnormal fluid/electrolyte transport such as cystic fibrosis-related pathologies.
Electroneutral exchange of chloride and bicarbonate ions across the cell membrane.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chloride-bicarbonate anion exchanger AE2.